• Home

  • About Us

    • Company Profile

    • Development Process

    • Strength

    • Enterprise Culture

  • Products

    • Listed Products

    • Linked API

    • Pipeline

  • Custom Services

    • Process Transfer

    • Process Validation and Registration Declaration

    • Analysis and Testing

    • API Production

  • Blog

    • Company News

    • EHS Information

    • Industry News

  • Join us

    • Recruitment Posts

    • Employee Benefits

    • Employee Activities

  • Contact Us

确认
Blog

Blog

Company News

EHS Information

Industry News

Implementation Regulations of the Pharmaceutical Administration Law of the People's Republic of China

Implementation Regulations of the Pharmaceutical Administration Law of the People's Republic of China

04

2025

/

06

Pharmacopoeia of the People's Republic of China, 2025 Edition

Pharmacopoeia of the People's Republic of China, 2025 Edition

03

2025

/

06

Policy Interpretation of the Announcement by the National Medical Products Administration on Further Improving the Issuance of Drug Production Licenses

Policy Interpretation of the Announcement by the National Medical Products Administration on Further Improving the Issuance of Drug Production Licenses

09

2025

/

05

Introduction to the major revisions and additions in the 2025 edition of the Chinese Pharmacopoeia, Part I

Introduction to the major revisions and additions in the 2025 edition of the Chinese Pharmacopoeia, Part I

08

2025

/

05

National Medical Products Administration Announcement on the Implementation of the 2025 Edition of the Pharmacopoeia of the People's Republic of China (No. 32 of 2025)

National Medical Products Administration Announcement on the Implementation of the 2025 Edition of the Pharmacopoeia of the People's Republic of China (No. 32 of 2025)

07

2025

/

05

Interpretation of Matters Concerning the Implementation of the 2025 Edition of the Chinese Pharmacopoeia (I)

Interpretation of Matters Concerning the Implementation of the 2025 Edition of the Chinese Pharmacopoeia (I)

07

2025

/

05

< 123 >

WhatsApp

5

WhatsApp

86020-8985 8964

E-mial

8

E-mial

pvreport@bio-current.com

Tel

9

Tel

86020-8985 8964


R & D Center

Address: Room 803, Building B3, Science and Technology Enterprise Accelerator, No.11 Kaiyuan Avenue, Huangpu District, Guangzhou

Telephone:020-8985 8964

Production Base

Address: No.80, Spring Equinox Road, Huangpu District, Guangzhou

Telephone:020-8328 9091

Adverse Drug Reaction/Event Feedback E-mail:pvreport@bio-current.com

er

   WeChat 

  • Home

  • About Us

    • Company Profile

    • Development Process

    • Strength

    • Enterprise Culture

  • Products

    • Listed Products

    • Linked API

    • Pipeline

  • Custom Services

    • Process Transfer

    • Process Validation and Registration Declaration

    • Analysis and Testing

    • API Production

  • Blog

    • Company News

    • EHS Information

    • Industry News

  • Join us

    • Recruitment Posts

    • Employee Benefits

    • Employee Activities

  • Contact Us

Copyright©2024 All Rights Reserved of Guangzhou Keruite Pharmaceutical Co., Ltd.

www.300.cn  SEO

Business License